United States Neuropeptide Y Receptor Type 2 Market Report 2018

January 2018 | 96 pages | ID: U4F19E5A6C6EN
QYResearch

Abstracts

In this report, the United States Neuropeptide Y Receptor Type 2 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Neuropeptide Y Receptor Type 2 in these regions, from 2012 to 2022 (forecast).

United States Neuropeptide Y Receptor Type 2 market competition by top manufacturers/players, with Neuropeptide Y Receptor Type 2 sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Gila Therapeutics Inc
• Novo Nordisk A/S
• XL-protein GmbH

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• XL-310
• NN-9748
• GT-002
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Obesity
• Epilepsy
• Type 2 Diabetes
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Neuropeptide Y Receptor Type 2 Market Report 2017

1 NEUROPEPTIDE Y RECEPTOR TYPE 2 OVERVIEW

1.1 Product Overview and Scope of Neuropeptide Y Receptor Type
1.2 Classification of Neuropeptide Y Receptor Type 2 by Product Category
  1.2.1 United States Neuropeptide Y Receptor Type 2 Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Neuropeptide Y Receptor Type 2 Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 XL-310
  1.2.4 NN-9748
  1.2.5 GT-002
  1.2.6 Others
1.3 United States Neuropeptide Y Receptor Type 2 Market by Application/End Users
  1.3.1 United States Neuropeptide Y Receptor Type 2 Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Obesity
  1.3.3 Epilepsy
  1.3.4 Type 2 Diabetes
  1.3.5 Others
1.4 United States Neuropeptide Y Receptor Type 2 Market by Region
  1.4.1 United States Neuropeptide Y Receptor Type 2 Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Neuropeptide Y Receptor Type 2 Status and Prospect (2012-2022)
  1.4.3 Southwest Neuropeptide Y Receptor Type 2 Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Neuropeptide Y Receptor Type 2 Status and Prospect (2012-2022)
  1.4.5 New England Neuropeptide Y Receptor Type 2 Status and Prospect (2012-2022)
  1.4.6 The South Neuropeptide Y Receptor Type 2 Status and Prospect (2012-2022)
  1.4.7 The Midwest Neuropeptide Y Receptor Type 2 Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Neuropeptide Y Receptor Type 2 (2012-2022)
  1.5.1 United States Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2012-2022)
  1.5.2 United States Neuropeptide Y Receptor Type 2 Revenue and Growth Rate (2012-2022)

2 UNITED STATES NEUROPEPTIDE Y RECEPTOR TYPE 2 MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Neuropeptide Y Receptor Type 2 Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Neuropeptide Y Receptor Type 2 Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Neuropeptide Y Receptor Type 2 Average Price by Players/Suppliers (2012-2017)
2.4 United States Neuropeptide Y Receptor Type 2 Market Competitive Situation and Trends
  2.4.1 United States Neuropeptide Y Receptor Type 2 Market Concentration Rate
  2.4.2 United States Neuropeptide Y Receptor Type 2 Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Neuropeptide Y Receptor Type 2 Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES NEUROPEPTIDE Y RECEPTOR TYPE 2 SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Neuropeptide Y Receptor Type 2 Sales and Market Share by Region (2012-2017)
3.2 United States Neuropeptide Y Receptor Type 2 Revenue and Market Share by Region (2012-2017)
3.3 United States Neuropeptide Y Receptor Type 2 Price by Region (2012-2017)

4 UNITED STATES NEUROPEPTIDE Y RECEPTOR TYPE 2 SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Neuropeptide Y Receptor Type 2 Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Neuropeptide Y Receptor Type 2 Revenue and Market Share by Type (2012-2017)
4.3 United States Neuropeptide Y Receptor Type 2 Price by Type (2012-2017)
4.4 United States Neuropeptide Y Receptor Type 2 Sales Growth Rate by Type (2012-2017)

5 UNITED STATES NEUROPEPTIDE Y RECEPTOR TYPE 2 SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Neuropeptide Y Receptor Type 2 Sales and Market Share by Application (2012-2017)
5.2 United States Neuropeptide Y Receptor Type 2 Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES NEUROPEPTIDE Y RECEPTOR TYPE 2 PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Gila Therapeutics Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Neuropeptide Y Receptor Type 2 Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novo Nordisk A/S
  6.2.2 Neuropeptide Y Receptor Type 2 Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 XL-protein GmbH
  6.3.2 Neuropeptide Y Receptor Type 2 Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 XL-protein GmbH Neuropeptide Y Receptor Type 2 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview

7 NEUROPEPTIDE Y RECEPTOR TYPE 2 MANUFACTURING COST ANALYSIS

7.1 Neuropeptide Y Receptor Type 2 Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Neuropeptide Y Receptor Type

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Neuropeptide Y Receptor Type 2 Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Neuropeptide Y Receptor Type 2 Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NEUROPEPTIDE Y RECEPTOR TYPE 2 MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Neuropeptide Y Receptor Type 2 Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Neuropeptide Y Receptor Type 2 Sales Volume Forecast by Type (2017-2022)
11.3 United States Neuropeptide Y Receptor Type 2 Sales Volume Forecast by Application (2017-2022)
11.4 United States Neuropeptide Y Receptor Type 2 Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Neuropeptide Y Receptor Type
Figure United States Neuropeptide Y Receptor Type 2 Market Size (K Pcs) by Type (2012-2022)
Figure United States Neuropeptide Y Receptor Type 2 Sales Volume Market Share by Type (Product Category) in 2016
Figure XL-310 Product Picture
Figure NN-9748 Product Picture
Figure GT-002 Product Picture
Figure Others Product Picture
Figure United States Neuropeptide Y Receptor Type 2 Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Neuropeptide Y Receptor Type 2 by Application in 2016
Figure Obesity Examples
Table Key Downstream Customer in Obesity
Figure Epilepsy Examples
Table Key Downstream Customer in Epilepsy
Figure Type 2 Diabetes Examples
Table Key Downstream Customer in Type 2 Diabetes
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Neuropeptide Y Receptor Type 2 Market Size (Million USD) by Region (2012-2022)
Figure The West Neuropeptide Y Receptor Type 2 Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Neuropeptide Y Receptor Type 2 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Neuropeptide Y Receptor Type 2 Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Neuropeptide Y Receptor Type 2 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Neuropeptide Y Receptor Type 2 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Neuropeptide Y Receptor Type 2 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Neuropeptide Y Receptor Type 2 Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Neuropeptide Y Receptor Type 2 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Neuropeptide Y Receptor Type 2 Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Neuropeptide Y Receptor Type 2 Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Neuropeptide Y Receptor Type 2 Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Neuropeptide Y Receptor Type 2 Sales Share by Players/Suppliers
Figure 2017 United States Neuropeptide Y Receptor Type 2 Sales Share by Players/Suppliers
Figure United States Neuropeptide Y Receptor Type 2 Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Neuropeptide Y Receptor Type 2 Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Neuropeptide Y Receptor Type 2 Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Neuropeptide Y Receptor Type 2 Revenue Share by Players/Suppliers
Figure 2017 United States Neuropeptide Y Receptor Type 2 Revenue Share by Players/Suppliers
Table United States Market Neuropeptide Y Receptor Type 2 Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Neuropeptide Y Receptor Type 2 Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Neuropeptide Y Receptor Type 2 Market Share of Top 3 Players/Suppliers
Figure United States Neuropeptide Y Receptor Type 2 Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Neuropeptide Y Receptor Type 2 Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Neuropeptide Y Receptor Type 2 Product Category
Table United States Neuropeptide Y Receptor Type 2 Sales (K Pcs) by Region (2012-2017)
Table United States Neuropeptide Y Receptor Type 2 Sales Share by Region (2012-2017)
Figure United States Neuropeptide Y Receptor Type 2 Sales Share by Region (2012-2017)
Figure United States Neuropeptide Y Receptor Type 2 Sales Market Share by Region in 2016
Table United States Neuropeptide Y Receptor Type 2 Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Neuropeptide Y Receptor Type 2 Revenue Share by Region (2012-2017)
Figure United States Neuropeptide Y Receptor Type 2 Revenue Market Share by Region (2012-2017)
Figure United States Neuropeptide Y Receptor Type 2 Revenue Market Share by Region in 2016
Table United States Neuropeptide Y Receptor Type 2 Price (USD/Pcs) by Region (2012-2017)
Table United States Neuropeptide Y Receptor Type 2 Sales (K Pcs) by Type (2012-2017)
Table United States Neuropeptide Y Receptor Type 2 Sales Share by Type (2012-2017)
Figure United States Neuropeptide Y Receptor Type 2 Sales Share by Type (2012-2017)
Figure United States Neuropeptide Y Receptor Type 2 Sales Market Share by Type in 2016
Table United States Neuropeptide Y Receptor Type 2 Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Neuropeptide Y Receptor Type 2 Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Neuropeptide Y Receptor Type 2 by Type (2012-2017)
Figure Revenue Market Share of Neuropeptide Y Receptor Type 2 by Type in 2016
Table United States Neuropeptide Y Receptor Type 2 Price (USD/Pcs) by Types (2012-2017)
Figure United States Neuropeptide Y Receptor Type 2 Sales Growth Rate by Type (2012-2017)
Table United States Neuropeptide Y Receptor Type 2 Sales (K Pcs) by Application (2012-2017)
Table United States Neuropeptide Y Receptor Type 2 Sales Market Share by Application (2012-2017)
Figure United States Neuropeptide Y Receptor Type 2 Sales Market Share by Application (2012-2017)
Figure United States Neuropeptide Y Receptor Type 2 Sales Market Share by Application in 2016
Table United States Neuropeptide Y Receptor Type 2 Sales Growth Rate by Application (2012-2017)
Figure United States Neuropeptide Y Receptor Type 2 Sales Growth Rate by Application (2012-2017)
Table Gila Therapeutics Inc Basic Information List
Table Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Sales Growth Rate (2012-2017)
Figure Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Sales Market Share in United States (2012-2017)
Figure Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Revenue Market Share in United States (2012-2017)
Table Novo Nordisk A/S Basic Information List
Table Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Sales Growth Rate (2012-2017)
Figure Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Sales Market Share in United States (2012-2017)
Figure Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Revenue Market Share in United States (2012-2017)
Table XL-protein GmbH Basic Information List
Table XL-protein GmbH Neuropeptide Y Receptor Type 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure XL-protein GmbH Neuropeptide Y Receptor Type 2 Sales Growth Rate (2012-2017)
Figure XL-protein GmbH Neuropeptide Y Receptor Type 2 Sales Market Share in United States (2012-2017)
Figure XL-protein GmbH Neuropeptide Y Receptor Type 2 Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neuropeptide Y Receptor Type
Figure Manufacturing Process Analysis of Neuropeptide Y Receptor Type
Figure Neuropeptide Y Receptor Type 2 Industrial Chain Analysis
Table Raw Materials Sources of Neuropeptide Y Receptor Type 2 Major Players/Suppliers in 2016
Table Major Buyers of Neuropeptide Y Receptor Type
Table Distributors/Traders List
Figure United States Neuropeptide Y Receptor Type 2 Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Neuropeptide Y Receptor Type 2 Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Neuropeptide Y Receptor Type 2 Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Neuropeptide Y Receptor Type 2 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Neuropeptide Y Receptor Type 2 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Neuropeptide Y Receptor Type 2 Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Neuropeptide Y Receptor Type 2 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Neuropeptide Y Receptor Type 2 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Neuropeptide Y Receptor Type 2 Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Neuropeptide Y Receptor Type 2 Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Neuropeptide Y Receptor Type 2 Sales Volume Share Forecast by Region (2017-2022)
Figure United States Neuropeptide Y Receptor Type 2 Sales Volume Share Forecast by Region (2017-2022)
Figure United States Neuropeptide Y Receptor Type 2 Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources